XML 31 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
HEP
UNEV
Common Stock
Additional Capital
Additional Capital
UNEV
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Non-controlling Interest
Non-controlling Interest
HEP
Non-controlling Interest
UNEV
Common stock outstanding at beginning of period (in shares) at Dec. 31, 2019       256,043,000                
Stockholders' equity at beginning of period at Dec. 31, 2019 $ 6,509,426     $ 2,560 $ 4,204,547   $ 4,744,120 $ 14,774 $ (2,987,808) $ 531,233    
Treasury stock outstanding at beginning of period (in shares) at Dec. 31, 2019                 94,196,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) (514,899)           (601,448)     86,549    
Dividends (229,493)           (229,493)          
Distributions to noncontrolling interest holders (89,001)                 (89,001)    
Other comprehensive loss, net of tax (1,312)             (1,312)        
Issuance of commons tock under incentive compensation plans (in shares)       3,000         847,000      
Issuance of common shares under incentive compensation plans         (26,938)       $ 26,938      
Equity-based compensation 31,654       29,460         2,194    
Purchase of treasury stock (in shares)                 283,000      
Purchase of treasury stock (7,642)               $ (7,642)      
Purchase of HEP units for restricted grants   $ (1,032)                 $ (1,032)  
Contributions from noncontrolling interests 23,899                 23,899    
Other 603       603              
Common stock outstanding at end of period (in shares) at Dec. 31, 2020       256,046,000                
Stockholders' equity at end of period at Dec. 31, 2020 5,722,203     $ 2,560 4,207,672   3,913,179 13,462 $ (2,968,512) 553,842    
Treasury stock outstanding at end of period (in shares) at Dec. 31, 2020                 93,632,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 663,254           558,324     104,930    
Dividends (57,663)           (57,663)          
Distributions to noncontrolling interest holders (75,395)                 (75,395)    
Other comprehensive loss, net of tax (10,791)             (10,791)        
Issuance of commons tock under incentive compensation plans (in shares)                 804,000      
Issuance of common shares under incentive compensation plans         (24,313)       $ 24,313      
Equity-based compensation 39,273       36,716         2,557    
Purchase of treasury stock (in shares)                 217,000      
Purchase of treasury stock (7,058)               $ (7,058)      
Purchase of HEP units for restricted grants   (2,548)                 (2,548)  
Contributions from noncontrolling interests 23,194                 23,194    
Other (4)           (4)          
Common stock outstanding at end of period (in shares) at Dec. 31, 2021       256,046,000                
Stockholders' equity at end of period at Dec. 31, 2021 6,294,465     $ 2,560 4,220,075   4,413,836 2,671 $ (2,951,257) 606,580    
Treasury stock outstanding at end of period (in shares) at Dec. 31, 2021                 93,045,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income (loss) 3,041,174           2,922,668     118,506    
Dividends (255,928)           (255,928)          
Distributions to noncontrolling interest holders (96,192)                 (96,192)    
Other comprehensive loss, net of tax (24,684)             (24,684)        
Issuance of common shares for HFC Transactions (in shares)       60,230,000                
Issuance of common shares for HFC Transactions 2,149,008     $ 602 2,148,406              
Issuance of commons tock under incentive compensation plans (in shares)                 849,000      
Issuance of common shares under incentive compensation plans         (42,962)       $ 42,962      
Equity-based compensation 30,318       28,474         1,844    
Purchase of treasury stock (in shares)                 27,001,000      
Purchase of treasury stock (1,378,390)               $ (1,378,390)      
Retirement of treasury stock (in shares)       (93,045,000)         (93,045,000)      
Retirement of treasury stock       $ (930)     (2,950,324)   $ 2,951,254      
Purchase of HEP units for restricted grants   $ (2,363) $ (58,275)     $ 19,735         $ (2,363) $ (78,010)
Equity attributable to HEP common unit issuance, net of tax 318,439       95,047         223,392    
Common stock outstanding at end of period (in shares) at Dec. 31, 2022       223,231,000                
Stockholders' equity at end of period at Dec. 31, 2022 $ 10,017,572     $ 2,232 $ 6,468,775   $ 4,130,252 $ (22,013) $ (1,335,431) $ 773,757    
Treasury stock outstanding at end of period (in shares) at Dec. 31, 2022                 26,152,000